Abiopharma

Clough Global Opportunities Fund is a closed-end investment fund, which operates with the objective of generating capital appreciation and income for its investors.

Additional info from NASDAQ:
Clough Global Dividend and Income Fund is a closed-end management investment company .Its investment objective is to provide a high level of total return. The Fund seeks to pursue this objective by applying a fundamental research-driven investment process and will invest in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed income securities, including both corporate and sovereign debt in both U.S. and non-U.S. markets. There is no assurance that the Fund will achieve its investment objective.

Additional info from NASDAQ:
The investment objective is to provide a high level of total return. A fundamental research-driven investment process will be applied in order to pursue this objective. Under normal circumstances, at least 80% of the net assets, including any borrowings for investment purposes, will be invested in securities in both U.S. and non-U.S. markets. The Fund intends to invest primarily in a managed mix of global equity securities. Up to 20% of the total assets may be invested in fixed income securities, including both corporate and sovereign debt in both U.S. and non-U.S. markets. The Fund will not invest more than 10% of total assets in below investment grade securities, and not more than 20% in securities of governments and companies in emerging markets.

Additional info from NASDAQ:
Clough Global Opportunities Fund is a closed-end investment fund, which operates with the objective of generating capital appreciation and income for its investors.